| scholarly article | Q13442814 |
| P50 | author | Lidia Blazquez-Llorca | Q41573095 |
| Mercè Masana | Q61162421 | ||
| Jochen Herms | Q87690483 | ||
| P2093 | author name string | Marianne B Müller | |
| Severin Filser | |||
| Saak V Ovsepian | |||
| Christiane Volbracht | |||
| Christian K E Jung | |||
| Anders Brandt Elvang | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| synaptic plasticity | Q1551556 | ||
| P304 | page(s) | 729-739 | |
| P577 | publication date | 2014-10-29 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions | |
| P478 | volume | 77 |
| Q90893924 | A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease |
| Q30251865 | Alzheimer's disease |
| Q52622902 | Association between BACE1 gene polymorphisms and focal seizures in a Chinese Han population. |
| Q38878922 | Aβ-Degrading Proteases: Therapeutic Potential in Alzheimer Disease |
| Q47658329 | BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer's Disease Pathology. |
| Q93152965 | BACE1 Translation: At the Crossroads Between Alzheimer's Disease Neurodegeneration and Memory Consolidation |
| Q50074018 | BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology |
| Q92287758 | BACE1 partial deletion induces synaptic plasticity deficit in adult mice |
| Q89445765 | BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains |
| Q41542097 | Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine? |
| Q53397736 | Click chemistry-mediated biotinylation reveals a function for the protease BACE1 in modulating the neuronal surface glycoproteome. |
| Q39051111 | Consecutive Analysis of BACE1 Function on Developing and Developed Neuronal Cells. |
| Q37458204 | Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels |
| Q38408049 | Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease |
| Q64253164 | Dual BACE1 and Cholinesterase Inhibitory Effects of Phlorotannins from -An In Vitro and in Silico Study |
| Q89225010 | Dual targeting agents for Aβ plaque/P-glycoprotein and Aβ plaque/nicotinic acetylcholine α4β2* receptors-potential approaches to facilitate Aβ plaque removal in Alzheimer's disease brain |
| Q36113733 | Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages |
| Q93082894 | Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation |
| Q93181542 | Facilitation of glutamate, but not GABA, release in Familial Alzheimer's APP mutant Knock-in rats with increased β-cleavage of APP |
| Q37329676 | Functions of the Alzheimer's Disease Protease BACE1 at the Synapse in the Central Nervous System. |
| Q42321743 | Gleevec shifts APP processing from a β-cleavage to a nonamyloidogenic cleavage |
| Q48239586 | Lamotrigine Reduces β-Site AβPP-Cleaving Enzyme 1 Protein Levels Through Induction of Autophagy |
| Q92669442 | MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties |
| Q36465116 | Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer's disease |
| Q36804007 | Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling |
| Q33575863 | Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2 |
| Q38864839 | Preclinical to phase II amyloid beta (Aβ) peptide modulators under investigation for Alzheimer's disease |
| Q93002897 | Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease |
| Q33625757 | Seeding and transgenic overexpression of alpha-synuclein triggers dendritic spine pathology in the neocortex |
| Q92714088 | Small interfering RNA delivery to the neurons near the amyloid plaques for improved treatment of Alzheimer׳s disease |
| Q38769710 | The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind |
| Q52147607 | The Association of Amyloid-β Protein Precursor With α- and β-Secretases in Mouse Cerebral Cortex Synapses Is Altered in Early Alzheimer's Disease. |
| Q60959834 | The Role of Glial Cells and Synapse Loss in Mouse Models of Alzheimer's Disease |
| Q92999242 | Tuning of Glutamate, But Not GABA, Release by an Intrasynaptic Vesicle APP Domain Whose Function Can Be Modulated by β- or α-Secretase Cleavage |
| Q35760228 | η-Secretase processing of APP inhibits neuronal activity in the hippocampus |
Search more.